A Study To Estimate The Effect of PF-06650833 On The Pharmacokinetics (PK) of Oral Contraceptive (OC)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 8, 2021

Primary Completion Date

December 16, 2021

Study Completion Date

December 16, 2021

Conditions

Healthy

Interventions

DRUG

PF-06650833

400 mg by mouth (PO) Once daily (QD) for 11 days

DRUG

Ethinyl estradiol (EE) and levonogestrel (LN)

Single dose of Oral tablet containing 30 ug EE and 150 ug of LN

Trial Locations (1)

Qps-Mra, Llc, South Miami